New Experimental Therapeutics of Virginia (NEXT Oncology) — Fairfax, Virginia

New Experimental Therapeutics of Virginia (NEXT Oncology) is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

New Experimental Therapeutics of Virginia (NEXT Oncology) has participated in 1 clinical trials.

Therapeutic areas: Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms.

Sponsors: Blueprint Medicines Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Experimental Therapeutics of Virginia (NEXT Oncology)?

New Experimental Therapeutics of Virginia (NEXT Oncology) has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Experimental Therapeutics of Virginia (NEXT Oncology) conducted?

New Experimental Therapeutics of Virginia (NEXT Oncology) has 1 clinical trials on record. Their work covers Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms.

Is New Experimental Therapeutics of Virginia (NEXT Oncology) accredited by Crixeo Clinical Trials?

New Experimental Therapeutics of Virginia (NEXT Oncology) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Experimental Therapeutics of Virginia (NEXT Oncology)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.